Article
Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients.
The Journal of antimicrobial chemotherapy - 1 Mar 2009
Descamps Diane, Lambert-Niclot Sidonie, Marcelin Anne-Geneviève, Peytavin Gilles, Roquebert Bénédicte, Katlama Christine, Yeni Patrick, Felices Mathieu, Calvez Vincent, Brun-Vézinet Françoise
Abstract excerpt
OBJECTIVE: The aim of the study was to identify a pattern of protease gene mutations associated with the virological response to darunavir/ritonavir-based regimens. PATIENTS AND METHODS: We analysed 153 treatment-experienced patients receiving a darunavir/ritonavir salvage regimen as a sole protease inhibitor (PI). Virological response was defined as an HIV-1 RNA load of <200 copies/mL at month 3. The impact of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
